The Associated Press reported that the FDA stipula

The Associated Press reported that the FDA stipulated the next Leronlimab trial must consist of a person in a lab coat, with a false mustache, holding a vial of the drug as he walks through the ICU twice a day. The person is permitted to hold up the vial and show it to the patient before pocketing it and waving a fond goodbye.

Upon conclusion of the test the FDA will announce that Leronlimab still is of no clinical benefit, and by the way we also need several more booster shots of the vaccine.